This is in line with recent proteomic studies demonstrating afamin as one of several blood markers for non-alcoholic fatty liver disease (NAFLD) examined in children (29) and in adults (30). This evidence concerns the gene AFM and metabolic dysfunction-associated steatotic liver disease.